Involvement of leukotriene B 4 in itching in a mouse model of ocular allergy

Experimental Eye Research

Volumn 98, Issue 1, 2012, Pages 97-103

  Andoh, Tsugunobu ^a   Sakai, Kazunari ^a   Urashima, Masahisa ^a   Kitazawa, Kayo ^a   Honma, Azusa ^a   Kuraishi, Yasushi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Allergic conjunctivitis; Allergic itch; Ig; Leukotriene B 4; LTB 4; Mast cell; PBS; Ragweed pollen; RP; Scratching

Indexed keywords

5 [2 (2 CARBOXYETHYL) 3 [6 (4 METHOXYPHENYL) 5 HEXENYLOXY]PHENOXY]VALERIC ACID; ALUMINUM POTASSIUM SULFATE; BETAMETHASONE; HISTAMINE; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR; POLLEN EXTRACT; TERFENADINE; ZILEUTON; ALLERGEN; DRUG DERIVATIVE; GLUCOCORTICOID; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYUREA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; LIPOXYGENASE INHIBITOR; ONO-LB 457; PHENYLPROPIONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EYE ALLERGY; EYELID; FATTY ACID SYNTHESIS; MALE; MAST CELL; MOUSE; NONHUMAN; OCULAR PRURITUS; POLLEN ALLERGY; PRIORITY JOURNAL; RAGWEED POLLEN; ALLERGIC CONJUNCTIVITIS; ANIMAL; BLOOD; DISEASE MODEL; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRAOCULAR DRUG ADMINISTRATION; PHYSIOLOGY; POLLEN; RAGWEED; SUBCUTANEOUS DRUG ADMINISTRATION;

ALLERGENS; AMBROSIA; ANIMALS; CONJUNCTIVITIS, ALLERGIC; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; HISTAMINE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HYDROXYUREA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAOCULAR; INJECTIONS, SUBCUTANEOUS; LEUKOTRIENE B4; LIPOXYGENASE INHIBITORS; MALE; MAST CELLS; MICE; MICE, INBRED ICR; PHENYLPROPIONATES; POLLEN; TERFENADINE;

EID: 84860244922     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2012.03.021     Document Type: Article

References (41)

1. Abelson M.B., McLaughlin J.T., Gomes P.J. Antihistamines in ocular allergy: are they all created equal?. Curr. Allergy. Asthma. Rep. 2011, 11:205-211.
2. Akman A., Irkec M., Orhan M., Erdener U. Effect of lodoxamide on tear leukotriene levels in giant papillary conjunctivitis associated with ocular prosthesis. Ocul. Immunol. Inflamm. 1998, 6:179-184.
3. 2, induces itch-associated responses in mice. Eur. J. Pharmacol. 1998, 353:93-96.
4. 4 action in anti-pruritic effects of emedastine in mice. Eur. J. Pharmacol. 2000, 406:149-152.
5. Andoh T., Kuraishi Y. Inhibitory effects of azelastine on substance P-induced itch-associated response in mice. Eur. J. Pharmacol. 2002, 436:235-239.
6. Andoh T., Kuraishi Y. Direct action of immunoglobulin G on primary sensory neurons through Fc gamma receptor I. FASEB. J. 2004, 18:182-184.
7. 4 receptor on the dorsal root ganglion neurons in mice. Brain. Res. Mol. Brain. Res. 2005, 137:263-266.
8. 4 action in mice. Eur. J. Pharmacol. 2006, 547:59-64.
9. 2 induces itch-associated responses through TP receptors in the skin in mice. J. Invest. Dermatol. 2007, 127:2042-2047.
10. 4 mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin. J. Invest. Dermatol. 2009, 129:2854-2860.
11. 4 in spontaneous itch-related behaviour in NC mice with atopic dermatitis-like skin lesions. Exp. Dermatol. 2011, 20:894-898.
12. Bundoc V.G., Keane-Myers A. Animal models of ocular allergy. Curr. Opin. Allergy. Clin. Immunol. 2003, 3:375-379.
13. 1 antihistamines. J. Investig. Allergol. Clin. Immunol. 2009, 19:11-18.
14. Fujishima H., Fukagawa K., Takano Y., Okamoto S., Nakagawa Y., Uchio E., Yokoi N., Fukushima A., Takamura E. The early efficacy of topical levocabastine in patients with allergic conjunctivitis. Allergol. Int. 2006, 55:301-303.
15. Fukushima Y., Nabe T., Mizutani N., Nakata K., Kohno S. Multiple cedar pollen challenge diminishes involvement of histamine in allergic conjunctivitis of guinea pigs. Biol. Pharm. Bull. 2003, 26:1696-1700.
16. Garceau D., Ford-Hutchinson A.W., Charleson S. 5-Lipoxygenase inhibitors and allergic conjunctivitis reactions in the guinea-pig. Eur. J. Pharmacol. 1987, 143:1-7.
17. Groneberg D.A., Bielory L., Fischer A., Bonini S., Wahn U. Animal models of allergic and inflammatory conjunctivitis. Allergy 2003, 58:1101-1113.
18. 4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 2003, 305:1212-1221.
19. Inagaki N., Nagao M., Igeta K., Kawasaki H., Kim J.F., Nagai H. Scratching behavior in various strains of mice. Skin. Pharmacol. Appl. Skin. Physiol. 2001, 14:87-96.
20. Irkec M., Bozkurt B. Epithelial cells in ocular allergy. Curr. Allergy. Asthma. Rep. 2003, 3:352-357.
21. Kato M., Kurose T., Oda T., Miyaji S. The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis. J. Ocul. Pharmacol. Ther. 2003, 19:315-324.
22. 3 receptors. J. Invest. Dermatol. 2004, 123:116-123.
23. Magone M.T., Chan C.C., Rizzo L.V., Kozhich A.T., Whitcup S.M. A novel murine model of allergic conjunctivitis. Clin. Immunol. Immunopathol. 1998, 87:75-84.
24. 4 release from mast cells in IgE-mediated airway hyperresponsiveness and inflammation. Am. J. Respir. Cell. Mol. Biol. 2009, 40:672-682.
25. Murphy R.C., Gijón M.A. Biosynthesis and metabolism of leukotrienes. Biochem. J. 2007, 405:379-395.
26. Nagaki Y., Hayasaka S., Kadoi C. Cataract progression in patients with atopic dermatitis. J. Cataract. Refract. Surg. 1999, 25:96-99.
27. 4 receptor in allergic conjunctivitis in mice. Eur. J. Pharmacol. 2009, 608:71-75.
28. Ohtsuka E., Kawai S., Ichikawa T., Nojima H., Kitagawa K., Shirai Y., Kamimura K., Kuraishi Y. Roles of mast cells and histamine in mosquito bite-induced allergic itch-associated responses in mice. Jpn. J. Pharmacol. 2001, 86:97-105.
29. Paus R., Schmelz M., Biro T., Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J. Clin. Invest. 2006, 116:1174-1186.
30. Rosario N., Bielory L. Epidemiology of allergic conjunctivitis. Curr. Opin. Allergy. Clin. Immunol. 2011, 11:471-476.
31. Sanchis-Merino M.E., Montero J.A., Ruiz-Moreno J.M., Rodriguez A.E., Pastor S. Comparative efficacy of topical antihistamines in an animal model of early phase allergic conjunctivitis. Exp. Eye. Res. 2008, 86:791-797.
32. Shii D., Oda T., Shinomiya K., Katsuta O., Nakamura M. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice. J. Ocul. Pharmacol. Ther. 2009, 25:321-328.
33. Shimada S.G., LaMotte R.H. Behavioral differentiation between itch and pain in mouse. Pain 2008, 139:681-687.
34. 4 receptors. Prostaglandins. Leukot. Essent. Fatty. Acids. 2003, 69:123-134.
35. 4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. J. Pharmacol. Exp. Ther. 2003, 307:1072-1078.
36. 4 in 5-lipoxygenase metabolite- and allergy-induced itch-associated responses in mice. Biol. Pharm. Bull. 2010, 33:1050-1053.
37. Tsukumo Y., Harada D., Manabe H. Pharmacological characterization of itch-associated response induced by repeated application of oxazolone in mice. J. Pharm. Sci. 2010, 113:255-262.
38. Woodward D.F., Nieves A.L., Friedlaender M.H. Characterization of receptor subtypes involved in prostanoid-induced conjunctival pruritus and their role in mediating allergic conjunctival itching. J. Pharmacol. Exp. Ther. 1996, 279:137-142.
39. Yamashita M., Kushihara M., Hirasawa N., Takasaki W., Takahagi H., Takayanagi M., Ohuchi K. Inhibition by troglitazone of the antigen-induced production of leukotrienes in immunoglobulin E-sensitized RBL-2H3 cells. Br. J. Pharmacol. 2000, 129:367-373.
40. 4 that mediates chemotaxis. Nature 1997, 387:620-624.
41. 4 receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J. Exp. Med. 2000, 192:421-432.